Serum antibodies against Haemophilus influenzae type b and tetanus at 2.5 years of age: A follow-up of 2 different regimens of infant vaccination

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 5, 1996, Pages 519-523

  Carlsson, Rose Marie ^a,c   Claesson, Bo A ^a   Lagergård, Teresa ^a   Käyhty, Helena ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CARRIER PROTEIN; DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; NEUTRALIZING ANTIBODY; TETANUS ANTIBODY; TETANUS TOXIN; TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFANT; NORMAL HUMAN; SWEDEN; TETANUS PROPHYLAXIS; VACCINATION;

EID: 0029851742     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609037951     Document Type: Article

References (15)

1. Carlsson RM, Claesson BA, Iwarson S, Lagergård T, Käyhty H. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines. Pediatr Infect Dis J 13: 27-33, 1994.
2. Mäkelä PH, Peltola H, Käyhty H, Jousimies H, Pettay O, Ruoslahti E, Sivonen A, Renkonen OV. Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis 136: S43-S50, 1977.
3. Manclark CR, Meade BD, Burstyn DB. Serological response to Bordetella pertussis. In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology. 3rd edn. Washington DC: American Society for Microbiology, 388-394, 1986.
4. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 147: 1100, 1983.
5. Bizzini B. Tetanus. In: Bermanier, ed. Bacterial vaccines, Orlando, FL: Academic Press, 37-68, 1984.
6. Claesson BA, Schneerson R, Lagergård T, Trollfors B, Taranger J, Johansson J, Bryla D, Robbins JB. Persistence of serum antibodies elicited by Haemophilus influenzae type b tetanus toxoid-conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatr Infect Dis J 10: 560-564, 1991.
7. Advisory Committee on Immunization Practices update. Report of Pedvax-HIB® lots with questionable immunogenicity. MMWR 41: 878-879, 1992.
8. Marwick C. Additional dose urged for some receiving Haemophilus influenzae vaccine in early '90s. JAMA 268: 3287, 1992.
9. Käyhty H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals 22: 397-402, 1994.
10. Claesson BA, Trollfors B, Anderson PW, Johansson J, Taranger J, Schneerson R, Robbins JB. Serum antibodies in 6-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 15: 170-172, 1996.
11. Kurikka S, Käyhty H, Saarinen L, Rönnberg PR, Eskola J, Mäkelä PH. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 172: 1268-1272, 1995.
12. Calandra GB, Lukacs LJ, Jonas LC, Santosham M, Ward JI, Greenberg DP, Daum RS, Matthews H, Vella PP, Ryan JL. Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses. Vaccine 11: S58-S62, 1993.
13. 197 conjugate vaccine. J Pediatr 119: 655-657, 1991.
14. Claesson BA, Trollfors B, Lagergård T, Taranger J, Bryla D, Otterman G, Cramton T, Yang Y, Reimer CB, Robbins JB, Schneerson R. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae typ b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr 112: 695-702, 1988.
15. Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Vaccine 11: S46-S51, 1993.